Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Medical Genetics

The Science of D-2-HGA: How the Diagnosis is Confirmed

At a Glance

D-2-HGA is confirmed by showing that the D form of 2-hydroxyglutarate—not the L form or 3-hydroxyglutarate—is elevated with a validated test, then interpreting the biochemical result alongside genetic testing when appropriate.

The biology of D-2-hydroxyglutaric aciduria (D-2-HGA) is a story of a chemical “look-alike” causing disruptions within the body’s cells. To understand this condition, you have to look at the mitochondria—the power plants of the cell—and how they process energy [1].

The Chemical Mimic: How D-2HG Works

In a healthy body, a molecule called alpha-ketoglutarate (α-KG) is a vital part of the energy cycle. It helps cells repair DNA and maintain the “volume settings” for genes (a process called epigenetics) [2].

In children with D-2-HGA, a substance called D-2-hydroxyglutarate (D-2HG) builds up to toxic levels. Because D-2HG is shaped almost exactly like α-KG, it acts as a “chemical mimic” [2][3]. It slides into the slots where α-KG is supposed to go, but instead of helping the cell, it blocks several critical enzymes. Research in laboratory and cancer models suggests that D-2HG may act as a “wrench in the gears” for several processes, though the exact way this explains a child’s symptoms is still being studied:

  • Epigenetic Erasers: Laboratory studies suggest D-2HG can block enzymes (like TET and JmjC) that help regulate the chemical tags on your DNA. This can lead to hypermethylation, which is thought to disrupt how the brain develops and functions [2][4].
  • Energy Production: In experimental models, D-2HG has been shown to inhibit Complex IV, a major part of the mitochondria’s energy-making machinery. This may lead to a drop in ATP (cellular energy) and the creation of reactive oxygen species [1][5].
  • Heart Muscle Stress: In the heart, these proposed energy shortages and byproducts may weaken the muscle, potentially leading to cardiomyopathy [1][6].

The Diagnostic Challenge: Why Precision Matters

Diagnosing D-2-HGA is difficult because there are several “look-alike” conditions that produce almost identical signals on standard tests.

The Problem with “Total” Results

A standard urine test often reports a value for “2-hydroxyglutaric acid.” However, this result is actually a combination of two different molecules: D-2HG and L-2HG. While they have the same name, they are mirror images of each other (like a left and right hand) and represent two entirely different diseases [7].

To confirm D-2-HGA when the biochemical result is non-specific, a lab uses enantiomer-specific testing (also called chiral testing). This specialized method uses a “chiral selector”—think of it like a glove that only fits one hand—to separate the D-form from the L-form and measure them individually [8][9]. A validated molecular diagnosis (genetic test) can also establish the subtype in the appropriate clinical context.

The 3-HG Pitfall

Another common error occurs during a standard test called GC-MS (Gas Chromatography-Mass Spectrometry). A molecule called 3-hydroxyglutarate (linked to glutaric aciduria type 1) often appears at the exact same spot on the test graph as 2-hydroxyglutarate [10].

Depending on the specific method used, laboratories might misidentify one for the other, leading to a wrong diagnosis [10][11]. To avoid this, doctors ensure the laboratory uses a validated method, such as LC-MS/MS, which can reliably tell these chemicals apart [12].

Checklist for a Complete Diagnosis

To be certain your child has D-2-HGA, your medical team should ideally have the following information in their reports:

  1. Enantiomer Breakdown: Does the report show separate values for the D and L forms of 2-hydroxyglutaric acid? [7][9]
  2. 3-HG Exclusion: Has the lab confirmed that the result is not actually 3-hydroxyglutarate (associated with GA1)? [10][12]
  3. Genetic Confirmation:
    • Type 1: Genetic testing should look for two mutations in the D2HGDH gene [13].
    • Type 2: Genetic testing should look for a specific “gain-of-function” mutation in the IDH2 gene [1][6].
  4. Biochemical and Molecular Match: Diagnosis is based on specialist interpretation of both genetic and biochemical evidence together. Additional samples (like plasma) are only obtained selectively if initial results are uncertain [14].

Common questions in this guide

Why does a total 2-hydroxyglutaric acid result not confirm D-2-HGA?
A total result combines D-2HG and L-2HG, which are mirror-image molecules associated with different disorders. A separate D/L measurement, usually through enantiomer-specific or chiral testing, is needed to show which form is elevated.
How do laboratories tell D-2HG apart from 3-hydroxyglutarate?
Some GC-MS methods can place 3-hydroxyglutarate and 2-hydroxyglutarate at the same location on the test graph. The laboratory should use a validated method, such as LC-MS/MS, that distinguishes these molecules.
What genetic findings are linked to D-2-HGA type 1 and type 2?
Type 1 is associated with two mutations in D2HGDH. Type 2 is associated with a gain-of-function mutation in IDH2. Genetic results should be interpreted together with biochemical findings by a qualified specialist.
What should be included in a complete D-2-HGA diagnosis?
A complete evaluation should identify whether D-2HG or L-2HG is elevated, exclude 3-hydroxyglutarate, and use a validated laboratory method. Genetic findings and biochemical results should match in the clinical context; additional samples such as plasma may be considered if initial results are unclear.
Can D-2HG affect the brain or heart?
Laboratory studies suggest that D-2HG can interfere with enzymes involved in gene regulation and mitochondrial energy production. These effects may contribute to abnormal brain development or cardiomyopathy, but the exact connection between the chemical changes and a child's symptoms is still being studied.
Who should review an unclear D-2-HGA test result?
A biochemical geneticist or other metabolic and genetics specialist can review the laboratory method, raw data, and genetic results. Ask whether the report provides separate D and L values and confirms that 3-hydroxyglutarate was excluded.

Get notified when new evidence is published on D-2-hydroxyglutaric aciduria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Disruption of mitochondrial bioenergetics, calcium retention capacity and cell viability caused by D-2-hydroxyglutaric acid in the heart.

    Ribeiro RT, Roginski AC, Marschner RA, et al.

    Biochimie 2023; (207()):153-164 doi:10.1016/j.biochi.2022.11.004.

    PMID: 36372308
  2. 2

    Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies.

    Madala HR, Punganuru SR, Arutla V, et al.

    Cancers 2018; (10(2)) doi:10.3390/cancers10020049.

    PMID: 29439493
  3. 3

    Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents.

    Wang P, Wu J, Ma S, et al.

    Cell reports 2015; (13(11)):2353-2361 doi:10.1016/j.celrep.2015.11.029.

    PMID: 26686626
  4. 4

    D-2-Hydroxyglutarate Is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant-Induced MIR148A Promoter Methylation.

    Li T, Cox CD, Ozer BH, et al.

    Molecular cancer research : MCR 2018; (16(6)):947-960 doi:10.1158/1541-7786.MCR-17-0367.

    PMID: 29545476
  5. 5

    Protective effects of the PPAR agonist bezafibrate against disruption of redox and energy homeostasis, neuronal death, astroglial reactivity, and neuroinflammation induced in vivo by D-2-hydroxyglutaric acid in rat brain.

    Ribeiro RT, Marcuzzo MB, Carvalho AVS, et al.

    European journal of pharmacology 2025; (987()):177186 doi:10.1016/j.ejphar.2024.177186.

    PMID: 39647572
  6. 6

    Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation.

    Geoerger B, Schiff M, Penard-Lacronique V, et al.

    Nature medicine 2023; (29(6)):1358-1363 doi:10.1038/s41591-023-02382-9.

    PMID: 37248298
  7. 7

    Quantitative Analysis of Oncometabolite 2-Hydroxyglutarate.

    Yuan BF

    Advances in experimental medicine and biology 2021; (1280()):161-172 doi:10.1007/978-3-030-51652-9_11.

    PMID: 33791981
  8. 8

    Chiral separation of 2-hydroxyglutaric acid on cinchonan carbamate based weak chiral anion exchangers by high-performance liquid chromatography.

    Calderón C, Horak J, Lämmerhofer M

    Journal of chromatography. A 2016; (1467()):239-245 doi:10.1016/j.chroma.2016.05.042.

    PMID: 27234847
  9. 9

    Enantioseparation of d,l-2-hydroxyglutaric acid by capillary electrophoresis with tandem mass spectrometry-Fast and efficient tool for d- and l-2-hydroxyglutaracidurias diagnosis.

    Švidrnoch M, Přibylka A, Bekárek V, et al.

    Journal of chromatography. A 2016; (1467()):383-390 doi:10.1016/j.chroma.2016.05.095.

    PMID: 27295961
  10. 10

    A simple method modification to increase separation of 2- and 3-hydroxyglutaric acid by GC-MS for clinical urine organic acids analysis.

    Dubland JA, Sinclair G, Vallance H, Rakić B

    Clinical biochemistry 2022; (105-106()):81-86 doi:10.1016/j.clinbiochem.2022.04.016.

    PMID: 35500672
  11. 11

    Enhanced differentiation between 3-hydroxyglutaric and 2-hydroxyglutaric acids facilitates diagnostic testing for glutaric aciduria type 1.

    Cyr D, Boutin M, Maranda B, Waters PJ

    JIMD reports 2024; (65(6)):433-441 doi:10.1002/jmd2.12447.

    PMID: 39512438
  12. 12

    Quantitation of plasma and urine 3-hydroxyglutaric acid, after separation from 2-hydroxyglutaric acid and other compounds of similar ion transition, by liquid chromatography-tandem mass spectrometry for the confirmation of glutaric aciduria type 1.

    Simon GA, Wierenga A

    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2018; (1097-1098()):101-110 doi:10.1016/j.jchromb.2018.09.007.

    PMID: 30218917
  13. 13

    Bilateral subdural hematomas and retinal hemorrhages mimicking nonaccidental trauma in a patient with D-2-hydroxyglutaric aciduria.

    Perales-Clemente E, Hewitt AL, Studinski AL, et al.

    JIMD reports 2021; (58(1)):21-28 doi:10.1002/jmd2.12188.

    PMID: 33728243
  14. 14

    Development and validation of an LC-MS/MS method for D- and L-2-hydroxyglutaric acid measurement in cerebrospinal fluid, urine and plasma: application to glioma.

    Dal-Bekar NE, Tuna G, Islekel S, Islekel GH

    Bioanalysis 2022; (14(19)):1271-1280 doi:10.4155/bio-2022-0168.

    PMID: 36453751

This page is for informational purposes only and does not replace medical advice. A metabolic specialist or biochemical geneticist should interpret your child's laboratory and genetic results.